Viracta Therapeutics (VIRX) Short Interest Ratio & Short Volume $0.02 +0.00 (+1.25%) As of 07/3/2025 12:58 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Viracta Therapeutics Short Interest DataViracta Therapeutics (VIRX) has a short interest of 13,900 shares, representing 0.04% of the float (the number of shares available for trading by the public). This marks a -38.50% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 1.08 million shares to cover all short positions.Current Short Interest13,900 sharesPrevious Short Interest22,600 sharesChange Vs. Previous Month-38.50%Dollar Volume Sold Short$243.25Short Interest Ratio0.1 Days to CoverLast Record DateJune 15, 2025Outstanding Shares39,744,000 sharesShort Percent of Float0.04%Today's Trading Volume31,733 sharesAverage Trading Volume1,081,578 sharesToday's Volume Vs. Average3% Short Selling Viracta Therapeutics? Sign up to receive the latest short interest report for Viracta Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVIRX Short Interest Over TimeVIRX Days to Cover Over TimeVIRX Percentage of Float Shorted Over Time Viracta Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202513,900 shares $243.25 -38.5%0.0%0.1 $0.02 5/31/202522,600 shares $413.58 -23.1%0.1%0.1 $0.02 5/15/202529,400 shares $514.50 -26.3%N/A0.2 $0.02 4/30/202539,900 shares $833.91 +405.1%N/A0.3 $0.02 4/15/20257,900 shares $132.72 -21.0%N/A0 $0.02 3/14/202528,200 shares $733.20 +108.9%N/A0 $0.03 2/14/202523,200 shares $396.72 -87.4%N/A0 $0.02 1/31/2025184,200 shares $27.91 thousand -25.1%0.7%0.1 $0.15 1/15/2025246,000 shares $40.34 thousand -59.7%0.9%0.1 $0.16 12/31/2024609,900 shares $98.13 thousand -79.7%2.2%0.2 $0.16 Get the Latest News and Ratings for VIRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viracta Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/20243,000,000 shares $608.10 thousand +89.9%10.7%1.4 $0.20 11/30/20241,580,000 shares $221.20 thousand -24.8%5.7%0.8 $0.14 11/15/20242,100,000 shares $317.10 thousand -21.9%7.5%2 $0.15 10/31/20242,690,000 shares $542.84 thousand +144.6%9.7%1.9 $0.20 10/15/20241,100,000 shares $241.56 thousand -17.3%4.0%1.7 $0.22 9/30/20241,330,000 shares $307.76 thousand +1.5%4.8%2.1 $0.23 9/15/20241,310,000 shares $328.81 thousand +4.0%4.7%2.1 $0.25 8/31/20241,260,000 shares $269.14 thousand -50.4%4.6%2.1 $0.21 8/15/20242,540,000 shares $885.19 thousand +178.5%9.2%4.8 $0.35 7/31/2024912,000 shares $436.85 thousand -6.4%3.3%8.5 $0.48 7/15/2024974,800 shares $517.62 thousand +35.2%3.5%10.7 $0.53 6/30/2024721,000 shares $392.01 thousand +1.7%2.6%7 $0.54 6/15/2024708,900 shares $477.66 thousand +3.8%2.6%6.7 $0.67 5/31/2024682,700 shares $477.89 thousand +2.1%2.5%6.3 $0.70 5/15/2024668,400 shares $561.46 thousand -4.4%2.4%6.5 $0.84 4/30/2024699,400 shares $573.23 thousand +1.9%2.5%6.3 $0.82 4/15/2024686,700 shares $535.63 thousand +6.0%2.5%6.2 $0.78 3/31/2024648,000 shares $660.96 thousand +2.2%2.4%6.8 $1.02 3/15/2024634,300 shares $631.76 thousand -7.1%2.3%5.7 $1.00 2/29/2024683,000 shares $556.65 thousand +0.6%2.5%5 $0.82 2/15/2024678,800 shares $433.75 thousand +4.5%2.5%4.5 $0.64 1/31/2024649,900 shares $370.44 thousand +0.4%2.4%4 $0.57 1/15/2024647,500 shares $384.23 thousand -1.9%2.4%3.8 $0.59 12/31/2023660,300 shares $376.37 thousand -14.9%2.5%3.8 $0.57 12/15/2023776,100 shares $361.97 thousand +19.3%2.9%4.6 $0.47 11/30/2023650,700 shares $316.89 thousand -8.2%2.4%4.9 $0.49 11/15/2023708,700 shares $425.50 thousand +3.0%2.6%7.3 $0.60 10/31/2023688,200 shares $424.28 thousand +12.0%2.6%7.5 $0.62 10/15/2023614,700 shares $436.44 thousand -2.7%2.3%7.6 $0.71 9/30/2023632,000 shares $657.28 thousand -4.3%2.4%7 $1.04INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)Right now, we’re witnessing a monumental shift in the world.Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. 9/15/2023660,200 shares $838.45 thousand -5.3%2.5%7.8 $1.27 8/31/2023697,200 shares $1.00 million -4.4%2.6%6.8 $1.44 8/15/2023729,100 shares $947.83 thousand +5.2%2.7%4.5 $1.30 7/31/2023692,900 shares $1.07 million -3.9%2.6%2.8 $1.55 7/15/2023721,000 shares $1.05 million -1.0%2.7%2.9 $1.45 6/30/2023728,500 shares $1.03 million -7.8%2.8%3 $1.41 6/15/2023789,900 shares $1.26 million +14.0%3.0%3.3 $1.59 5/31/2023693,200 shares $921.96 thousand +12.4%2.6%3.2 $1.33 5/15/2023616,700 shares $807.88 thousand -2.2%2.3%3.4 $1.31 4/30/2023630,800 shares $813.73 thousand +2.0%2.4%8.4 $1.29 4/15/2023618,300 shares $902.72 thousand -2.5%2.3%9.6 $1.46 3/31/2023634,000 shares $1.01 million -19.5%2.4%8.4 $1.59 3/15/2023787,800 shares $1.33 million +51.7%3.0%8.7 $1.69 2/28/2023519,200 shares $882.64 thousand +3.9%2.0%4.9 $1.70 2/15/2023499,500 shares $994.01 thousand +5.6%1.9%4.5 $1.99 1/31/2023473,000 shares $983.84 thousand -2.5%1.8%3.8 $2.08 1/15/2023485,300 shares $1.10 million +3.2%1.8%3.9 $2.26 12/30/2022470,300 shares $686.64 thousand -15.1%1.8%3.8 $1.46 12/15/2022553,600 shares $1.06 million -0.1%2.1%5.2 $1.92 11/30/2022553,900 shares $1.29 million +7.3%2.1%5.1 $2.32 11/15/2022516,200 shares $1.50 million +8.8%2.0%4.8 $2.90 10/31/2022474,600 shares $1.87 million -9.6%1.9%4.7 $3.93 10/15/2022525,100 shares $1.97 million -4.4%2.0%5.1 $3.75 9/30/2022549,000 shares $2.34 million +9.3%2.1%5 $4.27 9/15/2022502,100 shares $2.81 million -3.9%2.0%2.6 $5.59 8/31/2022522,300 shares $2.12 million +0.6%2.0%2.3 $4.05 8/15/2022519,100 shares $2.29 million -8.2%2.0%2.2 $4.42 7/31/2022565,400 shares $1.88 million -16.1%1.9%2.2 $3.32 7/15/2022673,800 shares $2.99 million -32.5%2.3%2.5 $4.44 6/30/2022998,500 shares $3.87 million -48.5%3.4%3.2 $3.88 6/15/20221,940,000 shares $4.85 million -3.0%6.5%6.1 $2.50 5/31/20222,000,000 shares $4.24 million +8.7%6.7%8.1 $2.12 5/15/20221,840,000 shares $3.44 million -7.1%6.2%7.3 $1.87 4/30/20221,980,000 shares $5.05 million +16.5%6.7%6.2 $2.55 4/15/20221,700,000 shares $6.90 million +20.6%5.7%5.2 $4.06 3/31/20221,410,000 shares $6.71 million +20.5%4.8%4.7 $4.76 3/15/20221,170,000 shares $2.61 million +13.6%3.9%4.2 $2.23 2/28/20221,030,000 shares $2.81 million +7.8%3.5%3.5 $2.73 2/15/2022955,900 shares $2.98 million +26.0%3.2%3 $3.12 1/31/2022758,800 shares $2.03 million +5.5%2.7%2.9 $2.68 1/15/2022719,100 shares $2.28 million -15.4%2.5%3.3 $3.17 12/31/2021849,800 shares $3.10 million -2.7%3.0%3.7 $3.65 12/15/2021873,100 shares $3.12 million +30.4%3.1%4 $3.57 11/30/2021669,400 shares $3.09 million -24.3%2.4%3.8 $4.61 11/15/2021884,500 shares $4.93 million -15.0%3.1%5.5 $5.57 10/29/20211,040,000 shares $6.12 million -7.1%3.5%6.6 $5.88 10/15/20211,120,000 shares $7.25 million -1.8%3.8%7.5 $6.47 9/30/20211,140,000 shares $9.14 million -5.0%3.8%8.5 $8.02 9/15/20211,200,000 shares $10.08 million -9.1%4.0%5.5 $8.40 8/31/20211,320,000 shares $12.17 million -15.9%4.4%4.9 $9.22INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)Right now, we’re witnessing a monumental shift in the world.Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. 8/13/20211,570,000 shares $16.11 million No Change5.3%5.7 $10.26 VIRX Short Interest - Frequently Asked Questions What is Viracta Therapeutics' current short interest? Short interest is the volume of Viracta Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 13,900 shares of VIRX short. 0.04% of Viracta Therapeutics' shares are currently sold short. Learn More on Viracta Therapeutics' current short interest. What is a good short interest percentage for Viracta Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Viracta Therapeutics' floating shares are currently sold short. Is Viracta Therapeutics' short interest increasing or decreasing? Viracta Therapeutics saw a decrease in short interest in June. As of June 15th, there was short interest totaling 13,900 shares, a decrease of 38.5% from the previous total of 22,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Viracta Therapeutics' short interest compare to its competitors? 0.04% of Viracta Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Viracta Therapeutics: Virax Biolabs Group Limited (0.51%), Adial Pharmaceuticals, Inc. (3.40%), Oragenics, Inc. (42.98%), Entero Therapeutics, Inc. (6.45%), Salarius Pharmaceuticals, Inc. (1.49%), Aspira Women's Health Inc. (1.19%), Alzamend Neuro, Inc. (17.46%), Onconetix, Inc. (13.51%), Scinai Immunotherapeutics Ltd. Sponsored ADR (10.56%), Atrinsic Inc. (3.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Viracta Therapeutics stock? Short selling VIRX is an investing strategy that aims to generate trading profit from Viracta Therapeutics as its price is falling. VIRX shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Viracta Therapeutics? A short squeeze for Viracta Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VIRX, which in turn drives the price of the stock up even further. How often is Viracta Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIRX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies VRAX Short Squeeze ADIL Short Squeeze OGEN Short Squeeze ENTO Short Squeeze SLRX Short Squeeze AWH Short Squeeze ALZN Short Squeeze ONCO Short Squeeze SCNI Short Squeeze PTIX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VIRX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viracta Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viracta Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIRX Stock Alerts